X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-18 | ANTX | Zakrzewski Joseph S | Dir | P - Purchase | $1.00 | +25,000 | 529,079 | +5% | +$25,046 | |||||
2024-11-18 | ANTX | Easom Eric | CEO | P - Purchase | $1.00 | +50,000 | 1,361,012 | +4% | +$49,970 | ||||||
2024-08-14 | ANTX | Leonard Braden Michael | 10% | P - Purchase | $1.04 | +1,500,000 | 5,749,432 | +35% | +$1,560,000 | ||||||
2024-08-09 | ANTX | Ra Capital Management, L.P. | 10% | S - Sale | $1.08 | -3,525,094 | 300,853 | -92% | -$3,807,102 | ||||||
2024-01-18 | ANTX | Zakrzewski Joseph S | Dir | S - Sale | $19.11 | -100,000 | 504,079 | -17% | -$1,911,410 | ||||||
2024-01-16 | ANTX | Aziz Kabeer | Dir | S - Sale | $19.65 | -100,000 | 2,373,500 | -4% | -$1,965,000 | ||||||
2024-01-16 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $19.65 | -100,000 | 2,373,500 | -4% | -$1,965,000 | ||||||
2024-01-12 | ANTX | Readnour Robin Shane | Dir | S - Sale | $21.92 | -1,425 | 485,073 | 0% | -$31,229 | ||||||
2024-01-10 | ANTX | Readnour Robin Shane | Dir | S - Sale | $21.93 | -3,669 | 485,792 | -1% | -$80,443 | ||||||
| D | 2024-01-09 | ANTX | Krause Kevin Michael | Chief Strategy Officer | S - Sale+OE | $20.14 | -7,417 | 1,914 | -79% | -$149,367 | |||||
| D | 2024-01-02 | ANTX | Krause Kevin Michael | Chief Strategy Officer | S - Sale+OE | $20.12 | -2,583 | 1,914 | -57% | -$51,967 | |||||
2024-01-02 | ANTX | Easom Eric | CEO | S - Sale | $20.09 | -2,777 | 1,212,012 | 0% | -$55,802 | ||||||
2023-11-14 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.15 | -1,810 | 2,473,500 | 0% | -$29,224 | ||||||
2023-11-14 | ANTX | Aziz Kabeer | Dir, 10% | S - Sale | $16.15 | -1,810 | 2,473,500 | 0% | -$29,224 | ||||||
| M | 2023-09-29 | ANTX | Aziz Kabeer | Dir, 10% | S - Sale | $16.27 | -104,773 | 2,475,310 | -4% | -$1,704,513 | |||||
| M | 2023-09-29 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.27 | -104,773 | 2,475,310 | -4% | -$1,704,513 | |||||
| M | 2023-09-27 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.11 | -9,357 | 2,580,083 | 0% | -$150,708 | |||||
| M | 2023-09-27 | ANTX | Aziz Kabeer | Dir, 10% | S - Sale | $16.11 | -9,357 | 5,168,682 | 0% | -$150,708 | |||||
2023-09-13 | ANTX | Aziz Kabeer | Dir, 10% | S - Sale | $16.00 | -400 | 2,589,440 | 0% | -$6,400 | ||||||
2023-09-13 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.00 | -400 | 2,589,440 | 0% | -$6,400 | ||||||
| M | 2023-09-06 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.03 | -7,140 | 2,589,840 | 0% | -$114,484 | |||||
| M | 2023-09-06 | ANTX | Aziz Kabeer | Dir, 10% | S - Sale | $16.03 | -7,140 | 2,589,840 | 0% | -$114,484 | |||||
2023-08-23 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.00 | -400 | 2,596,980 | 0% | -$6,400 | ||||||
2023-08-23 | ANTX | Aziz Kabeer | Dir, 10% | S - Sale | $16.00 | -400 | 2,596,980 | 0% | -$6,400 | ||||||
2023-08-18 | ANTX | Ra Capital Management, L.P. | 10% | P - Purchase | $9.00 | +1,777,778 | 5,551,295 | +47% | +$16,000,002 | ||||||
2023-05-15 | ANTX | Easom Eric | CEO | P - Purchase | $5.38 | +10,000 | 1,214,789 | +1% | +$53,770 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |